Platelet-Rich Protein and the Endometrium

Hadassah Medical Organization50 enrolled

Overview

Platelet-rich plasma (PRP) may promote the endometrial growth and improve pregnancy outcome of patients with thin endometrium undergoing ART treatments.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Infertility

Interventions

PRP injectionOTHER

autologous intrauterine infusion of PRP

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 54 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women undergoing a frozen thawed embryo transfer cycle with poor endometrial response to estrogen (\< 7 mm) after at least two standard preparation protocols, of which one was canceled due to thin endometrium Exclusion Criteria: * none

Locations (1)

Hadassah Medical Organization

Jerusalem, Israel

Outcomes

Primary Outcomes

endometrial thickness >7mm

Time frame: 1 month

Secondary Outcomes

Positive serum pregnancy test

Time frame: 14 days post embryo transfer

Central Contacts

Ronit Kochman, MD

CONTACT

+972 508946414 kochman@hadassah.org.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.